Dr. Viswanathan is an Affiliate Scientist at the University Health Network, and an Assistant Professor at the University of Toronto. Her research is focused on anti-inflammatory approaches to treat inflammatory diseases including using enhanced mesenchymal stromal cells (MScs) and ex-vivo polarized macrophages. As a translational scientist, she has overseen clinical translation of 13 cell-based therapies, including as co-PI on a pioneering MSC trial to treat OA patients. Dr. Viswanathan co-chairs a Cell Therapy Stakeholder’s Group (CTSG) that has bilateral interactions with Health Canada. Dr. Viswanathan is an expert member of ISO TC 276 focused on standards in cell-and gene therapies, and is an elected formal liaison between ISCT and ISO TC276. She also sits on ISCT’s MSC and NA LRA committees, and is an associate editor of Cytotherapy.